🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary purpose of the study is to assess the effect of hepatic impairm...
Status
Completed
Location
Miami, Florida
Start Date
2022-04-29
Trial ID
NCT05404529
Treatments Being Tested
The purpose of this study is to evaluate the clinical efficacy, safety and ...
Status
Completed
Location
Birmingham, Alabama
Start Date
2019-12-13
Trial ID
NCT04201093
The purpose of this study is to evaluate the safety and efficacy of long-te...
Status
Completed
Location
Birmingham, Alabama
Start Date
2021-02-24
Trial ID
NCT04760769
Treatments Being Tested
The purpose of this trial is to determine the absorption, metabolism, and e...
Status
Completed
Location
Covance Clinical Research Unit, Inc.
Start Date
2020-02-04
Trial ID
NCT04241393
Treatments Being Tested
The primary purpose of the study is to evaluate the bioequivalence (BE) of ...
Status
Completed
Location
Los Alamitos, California
Start Date
2022-12-15
Trial ID
NCT05610189
Treatments Being Tested
This study will assess the relative bioavailability of two different Oral f...
Status
Completed
Location
Acpru /Id# 275870
Start Date
2025-03-26
Trial ID
NCT06895356
Treatments Being Tested
The purpose of this study is to assess the effect of tavapadon on the chang...
Status
Completed
Location
Pheonix, Arizona
Start Date
2020-09-23
Trial ID
NCT04542499
This is an expanded access program (EAP) for eligible participants. This pr...
Status
Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT07158827
Treatments Being Tested
The primary purpose is to assess the effect of renal impairment on the PK o...
Status
Completed
Location
Jacksonville, Florida
Start Date
2022-05-10
Trial ID
NCT05404542
Treatments Being Tested
The primary purpose of this study is to evaluate the effect of carbamazepin...
Status
Completed
Location
Madison, Wisconsin
Start Date
2022-10-19
Trial ID
NCT05581823
Treatments Being Tested